Macquarie Group’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,528
Closed -$16.6K 1641
2025
Q1
$16.6K Buy
+1,528
New +$15.4K ﹤0.01% 1600
2023
Q1
Sell
-126,072
Closed -$2.42M 1705
2022
Q4
$2.42M Sell
126,072
-59,390
-32% -$1.26M ﹤0.01% 1151
2022
Q3
$3.48M Buy
+185,462
New +$3.81M ﹤0.01% 1077
2020
Q2
Sell
-5,446
Closed -$87K 2356
2020
Q1
$87K Buy
+5,446
New +$77K ﹤0.01% 1669

Other funds holding AHCO

Macquarie Group's AHCO Position: Q2 2025 in Review

Macquarie Group sold out of AdaptHealth (AHCO) in Q2 2025, closing a stake of 1,528 shares — an estimated $16.6K sold.

Macquarie Group first reported a position in AHCO in Q1 2020 and held it in 4 quarters. The position peaked at $3.48M in Q3 2022. 218 funds tracked by Wall St. Rank hold AHCO as of Q2 2025.

  • Macquarie Group reported no remaining AdaptHealth position as of Q2 2025 after selling out during the quarter.
  • Macquarie Group sold 1,528 AdaptHealth shares in Q2 2025, an estimated $16.6K.
  • Macquarie Group first reported a position in AdaptHealth in Q1 2020 and held it in 4 quarters.
  • Macquarie Group's AdaptHealth position peaked at $3.48M in Q3 2022.
  • 218 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2025.

Based on Macquarie Group's 13F filing for Q2 2025, filed 14 Aug 2025.